Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI

(SAN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Paris
01/22/2021 01/25/2021 01/26/2021 01/27/2021 01/28/2021 Date
81.46(c) 81.5(c) 81.07(c) 79.07(c) 78.87 Last
2 012 106 1 820 478 2 053 028 3 352 652 607 930 Volume
+0.05% +0.05% -0.53% -2.47% -0.25% Change
More quotes
Financials
Sales 2020 36 746 M 44 419 M 44 419 M
Net income 2020 10 246 M 12 386 M 12 386 M
Net Debt 2020 8 676 M 10 487 M 10 487 M
P/E ratio 2020 8,51x
Yield 2020 4,08%
Sales 2021 37 521 M 45 355 M 45 355 M
Net income 2021 5 541 M 6 698 M 6 698 M
Net Debt 2021 6 355 M 7 682 M 7 682 M
P/E ratio 2021 17,7x
Yield 2021 4,22%
Capitalization 99 342 M 120 B 120 B
EV / Sales 2020 2,94x
EV / Sales 2021 2,82x
Nbr of Employees 100 409
Free-Float 88,9%
More Financials
Company
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (84.1%): for the treatment of cardio-vascular diseases, thrombosis, central nervous system disorders (insomnia, multiple sclerosis, epilepsy), cancers, allergies, etc. Moreover, Sanofi-Aventis markets OTC products and generic drugs; - human vaccines (15.9%): pediatric vaccines,... 
Sector
Pharmaceuticals
Calendar
02/05Earnings Release
More about the company
Notations Surperformance© of Sanofi
Trading Rating : Investor Rating :
More Ratings
All news about SANOFI
01:33aPRESS RELEASE : Evotec Starts Clinical Development of Chikungunya Antibody toget..
DJ
01/27EU Clashes With AstraZeneca Over Covid-19 Vaccine Shortfall
DJ
01/27France's Sanofi to help rival Pfizer-BioNTech make vaccines
AQ
01/27GLOBAL MARKETS LIVE: Boeing, Microsoft, AMD…
01/27THE LATEST : AstraZeneca, EU to hold vaccine delivery talks
AQ
01/27SANOFI : Gets a Buy rating from JP Morgan
MD
01/27Sanofi Lends Hand to BioNTech, Pfizer on COVID-19 Vaccine Production
MT
01/27Sanofi to Collaborate With BioNTech on Coronavirus Vaccine Production -- Upda..
DJ
01/27Sanofi to Help With Production, Supply of BioNTech-Pfizer COVID-19 Vaccine in..
MT
01/27Sanofi to Collaborate With BioNTech on Coronavirus Vaccine Production
DJ
01/27SANOFI : to provide support to BioNTech in manufacturing their COVID-19 vaccine ..
PU
01/27PRESS RELEASE : Just - Evotec Biologics Expands Contract with the Department of ..
DJ
01/26Sanofi to help produce 100 million Pfizer/BioNTech vaccine doses
RE
01/26Sanofi to help produce 100 mln Pfizer/BioNTech vaccine doses
RE
01/26NANOBIOTIX : Partners with Sanofi on Gene Therapy Development Project
MT
More news
News in other languages on SANOFI
01/27STOCK MARKET PARIS : Paris fléchit, la Fed et les vaccinations en ligne de mire
01/27Résumé des principales informations économiques du mercredi 27 janvier 2021
01/27SANOFI : va fabriquer le vaccin de PFIZER/BIONTECH
01/27STOCK MARKET PARIS : Paris repart à la baisse à mi-séance et perd 0,92%
01/27BIONTECH : Sanofi-Beteiligung an Vakzin-Produktion ändert nichts an Liefermenge ..
More news
Analyst Recommendations on SANOFI
More recommendations
Stock Trading Strategies
SANOFI - 2020
Good timing to go long again
BUY
More Stock Trading Analysis
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | SAN | FR0000120578 | MarketScreener
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 100,38 €
Last Close Price 79,07 €
Spread / Highest target 48,0%
Spread / Average Target 26,9%
Spread / Lowest Target -11,5%
EPS Revisions
Managers and Directors
NameTitle
Paul Hudson Chief Executive Officer & Director
Serge Weinberg Chairman
Jean-Baptiste Chasseloup de Chatillon Chief Financial Officer & Executive Vice President
John C. Reed EVP & Global Head-Research & Development
Nestle Frank Global Head-Immunology Therapeutic Research Area
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI0.47%120 167
JOHNSON & JOHNSON6.67%441 951
ROCHE HOLDING AG3.62%309 011
NOVARTIS AG0.20%212 810
PFIZER INC.-1.55%201 436
MERCK & CO., INC.-5.78%194 990